MARKET

XAIR

XAIR

Beyond Air Inc
NASDAQ
0.4680
+0.0014
+0.30%
After Hours: 0.4520 -0.016 -3.42% 19:19 07/02 EDT
OPEN
0.4630
PREV CLOSE
0.4666
HIGH
0.4799
LOW
0.4365
VOLUME
185.61K
TURNOVER
--
52 WEEK HIGH
4.780
52 WEEK LOW
0.3345
MARKET CAP
6.74M
P/E (TTM)
-0.1168
1D
5D
1M
3M
1Y
5Y
1D
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga · 3d ago
Weekly Report: what happened at XAIR last week (0622-0626)?
Weekly Report · 6d ago
Beyond Air Earnings Call: Growth Momentum Meets High Stakes
TipRanks · 06/27 00:01
Beyond Air Unveils New Leadership and Growth Outlook
TipRanks · 06/26 21:08
Midday Fly By: On Semi to acquire Synaptics, OpenAI leans toward 2027 IPO
TipRanks · 06/26 16:06
Morning Movers: Shares of On Semi, Synaptics diverge after $7B transaction
TipRanks · 06/26 13:05
Transcript: Beyond Air Q4 2026 Earnings Conference Call
Benzinga · 06/26 12:30
Beyond Air Sees Calendar Year 2027 Sales $16.000M-$18.000M
Benzinga · 06/26 11:21
More
About XAIR
Beyond Air, Inc. is a commercial-stage medical device and biopharmaceutical company dedicated to harnessing the power of endogenous and exogenous nitric oxide (NO) to improve the lives of patients suffering from respiratory illnesses, neurological disorders, and solid tumors. Its segments include Beyond Air, Beyond Cancer, and NeuroNos. It has received United States Food and Drug Administration approval for its first system, LungFit PH, for the treatment of term and near-term neonates with hypoxic respiratory failure. The Company is advancing its other LungFit systems in clinical trials for the treatment of severe lung infections such as viral community-acquired pneumonia (including COVID-19) and nontuberculous mycobacteria. It has also partnered with The Hebrew University of Jerusalem to advance a pre-clinical program dedicated to the treatment of autism spectrum disorder and other neurological disorders. Its product pipeline includes LungFit PH, LungFit PRO, LungFit GO, and others.

Webull offers Beyond Air Inc stock information, including NASDAQ: XAIR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, XAIR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading XAIR stock methods without spending real money on the virtual paper trading platform.